Comprehensive Cell Solutions (CCS) is a fast-growing #biotechnology division within NYBloodCenter, contributing to the advancement of immunotherapy via research, clinical trials, and experience. The divisions offers an extensive suit of R&D products and services that have been designed to seamlessly facilitate partnerships, innovation support, and joint-ventures. CCS is quickly on its way to becoming a world renown pioneer of research and development in new generations of blood and cell-based therapies that address critical, unmet patient needs.

Contact NYBC & Comprehensive Cell Solutions
Visit Website